Susan Lerner

12.1k citations

154 papers · 8.6k indexed · 2 hit papers · h-index 46

Impact in

Genetics top 0.02%
- Chronic Lymphocytic Leukemia Research
Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment

Papers in

Genetics 131
- Chronic Lymphocytic Leukemia Research 131
Pathology and Forensic Medicine 104
- Lymphoma Diagnosis and Treatment 104

Co-authors: Michael J. Keating Hagop M. Kantarjian Susan O’Brien William G. Wierda Charles Koller Jörge E. Cortes Deborah A. Thomas Francis J. Giles
Journals: Blood (57 papers)Journal of Clinical Oncology (25 papers)Cancer (12 papers)British Journal of Haematology (5 papers)Leukemia (3 papers)
Partner nations: United States Australia Mexico

In The Last Decade

Susan Lerner

149 papers receiving 8.3k citations

Hit Papers

align trajectories log scale

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia 2008 · 508 citations

Peers

Countries citing papers authored by Susan Lerner

Since Specialization

Citations

This map shows the geographic impact of Susan Lerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Lerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Lerner more than expected).

Fields of papers citing papers by Susan Lerner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Lerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Lerner. The network helps show where Susan Lerner may publish in the future.

Co-authors

The 25 scholars most cited alongside Susan Lerner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Susan Lerner Line = papers co-authored together Susan Lerner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Civilidad menstrual y género en mujeres mexicanas : un estudio de caso en el estado de Morelos Estudios Sociológicos de El Colegio de México ·Mohammad Abdullah Alotaibi, Susan Lerner, Wei-chung Ko	2014	4
2	Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes Leukemia & lymphoma ·Ohad Benjamini, Preetesh Jain, Long Trinh, Wei Qiao, Sara S. Strom, Susan Lerner, Xuemei Wang, Jan A. Burger, Alessandra Ferrajoli, Hagop M. Kantarjian, Susan O’Brien, William G. Wierda, Zeev Estrov, Michael J. Keating	2014	102
3	Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia Supportive Care in Cancer ·Chris L. Pashos, Christopher R. Flowers, Neil E. Kay, Mark A. Weiss, Nicole Lamanna, Charles M. Farber, Susan Lerner, Jeff P. Sharman, David L. Grinblatt, Ian W. Flinn, M. Kozloff, Arlene S. Swern, مصطفي ده پناه, Kristen Sullivan, Gale Harding, Zeba M. Khan	2013	29
4	PCN103 Variation in Health-Related Quality of Life by Age Among Patients With Chronic Lymphocytic Leukemia Value in Health ·R.S. Herne-Smith, Christopher R. Flowers, Mark A. Weiss, Nicole Lamanna, Charles M. Farber, Thomas J. Kipps, Susan Lerner, Neil E. Kay, Jeff P. Sharman, David L. Grinblatt, Ian W. Flinn, Mark Kozloff, Arlene S. Swern, LIANG Bin-Yong, مصطفي ده پناه, Kathleen A. Sullivan, Gale Harding, Michael J. Keating	2012	1
5	Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia Leukemia & lymphoma ·John Hornberger, Carolina Reyes, Ashwini Shewade, Susan Lerner, V. V. Chinte -, Leona C. Han, Hialy Gutierrez, Sacha Satram‐Hoang, Michael J. Keating	2011	27
6	De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience Blood ·Constantine S. Tam, Tait D. Shanafelt, William G. Wierda, Lynne V. Abruzzo, Daniel L. Van Dyke, Susan O’Brien, Alessandra Ferrajoli, Susan Lerner, Alice Lynn, Neil E. Kay, Michael J. Keating	2009	114
7	A phase 2 study of yttrium‐90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia Cancer ·Nitin Jain, William G. Wierda, Alessandra Ferrajoli, Franklin C. Wong, Susan Lerner, Michael J. Keating, Susan O’Brien	2009	13
8	Salud reproductiva y condiciones de vida en México Susan Lerner, Borrego Milagros	2008	2
9	The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy Leukemia & lymphoma ·Constantine S. Tam, Susan O’Brien, Susan Lerner, Issa F. Khouri, Alessandra Ferrajoli, Stefan Faderl, Mary Browning, Apostolia M. Tsimberidou, Hagop M. Kantarjian, William G. Wierda	2007	72
10	Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia Cancer ·Susan O’Brien, Hagop M. Kantarjian, Deborah A. Thomas, Jörge E. Cortes, Francis J. Giles, William G. Wierda, Charles Koller, Alessandra Ferrajoli, Mary Browning, Susan Lerner, Maher Albitar, Michael J. Keating	2003	179
11	Significance of the levels of bone marrow lymphoid infiltrate in chronic lymphocytic leukemia patients with nodular partial remission Leukemia ·H. G. L., MJ Keating, Susan Lerner, S O'Brien, Maher Albitar	2002	8
12	Higher Levels of Surface CD20 Expression on Circulating Lymphocytes Compared With Bone Marrow and Lymph Nodes in B-Cell Chronic Lymphocytic Leukemia American Journal of Clinical Pathology ·Yang O. Huh, Michael J. Keating, Gianluca Monturano, Iman Jilani, Susan Lerner, Maher Albitar	2001	54
13	Prediction of Prognosis Following Fludarabine Used as Secondary Therapy for Chronic Lymphocytic Leukemia Leukemia & lymphoma ·Michael J. Keating, Terry L. Smith, Susan Lerner, Susan O’Brien, L. E. Robertson, Hagop M. Kantarjian, Emil J. Freireich	2000	29
14	Oceanographic Research Using Remotely Operated Underwater Robotic Vehicles: Exploration of Hydrothermal Vent Sites On The Mid-Atlantic Ridge At 37°North 32°West Marine Technology Society Journal ·Ralf Bachmayer, Susan E. Humphris, Daniel J. Fornari, Cindy Lee Van Dover, Jonathan C. Howland, Yuxiao Guo, R. L. Elder, Phylis Morrison, Priyadarshini Sharma, Ann Noble, Susan Lerner	1998	26
15	Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial Therapy Blood ·Michael J. Keating, Susan O’Brien, Susan Lerner, Charles Koller, Miloslav Beran, L. E. Robertson, Emil J. Freireich, Elihu H. Estey, Hagop M. Kantarjian	1998	345
16	Case/control study of the role of splenectomy in chronic lymphocytic leukemia. Journal of Clinical Oncology ·John F. Seymour, Marie M. Sahm, Susan Lerner, Raphael E. Pollock, Michael J. Keating	1997	28
17	Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft‐versus‐host disease British Journal of Haematology ·Issa F. Khouri, Donna Przepiorka, Koen van Besien, Susan O’Brien, Kazuki Akiba, Susan Lerner, Rakesh Mehra, Huibert M. Vriesendorp, Börje S. Andersson, Sergio Giralt, Martin Körbling, Michael J. Keating, Richard Champlin	1997	77
18	Salud reproductiva en el medio rural mexicano: aspectos sustantivos y metodológicos para el análisis de las trayectorias reproductivas Series Históricas ·Susan Lerner, Seiroku Sakai	1994	0
19	L-Asparaginase and PEG Asparaginase— Past, Present, and Future Leukemia & lymphoma ·Michael J. Keating, Jean-Claude Jarrousseau, Susan Lerner, D H Ho	1993	166
20	Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment [see comments] Blood ·S O'Brien, Hagop M. Kantarjian, Miloslav Beran, Terry Smith, Charles Koller, Elihu H. Estey, L. E. Robertson, Susan Lerner, Michael J. Keating	1993	232

About Susan Lerner

Susan Lerner is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Hematology and Public Health, Environmental and Occupational Health, having authored 154 papers that have together received 8.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (131 papers), Lymphoma Diagnosis and Treatment (104 papers), Immunodeficiency and Autoimmune Disorders (47 papers), Acute Lymphoblastic Leukemia research (30 papers), Advanced Breast Cancer Therapies (18 papers), Chronic Myeloid Leukemia Treatments (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Mexican Socioeconomic and Environmental Dynamics (4 papers). The work is most often cited by research in Genetics (7.0k citations), Pathology and Forensic Medicine (6.0k citations), Immunology (3.4k citations), Hematology (1.6k citations) and Oncology (1.4k citations). Susan Lerner has collaborated with scholars based in United States, Australia and Mexico. Frequent co-authors include Michael J. Keating, Hagop M. Kantarjian, Susan O’Brien, William G. Wierda, Charles Koller, Jörge E. Cortes, Susan O’Brien, Deborah A. Thomas, Francis J. Giles and Alessandra Ferrajoli. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, British Journal of Haematology and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact